BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 28072395)

  • 1. Evaluation of adaptive treatment planning for patients with non-small cell lung cancer.
    Zhong H; Siddiqui SM; Movsas B; Chetty IJ
    Phys Med Biol; 2017 Jun; 62(11):4346-4360. PubMed ID: 28072395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive radiotherapy for NSCLC patients: utilizing the principle of energy conservation to evaluate dose mapping operations.
    Zhong H; Chetty IJ
    Phys Med Biol; 2017 Jun; 62(11):4333-4345. PubMed ID: 28475493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of a hybrid finite-element based registration method to quantify heterogeneous tumor response for adaptive treatment for lung cancer patients.
    Sharifi H; Zhang H; Bagher-Ebadian H; Lu W; Ajlouni MI; Jin JY; Kong FS; Chetty IJ; Zhong H
    Phys Med Biol; 2018 Mar; 63(6):065017. PubMed ID: 29480158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the anatomic changes and dosimetric consequences in adaptive CRT of non-small-cell lung cancer using deformable CT and CBCT image registration.
    Ma C; Hou Y; Li H; Li D; Zhang Y; Chen S; Yin Y
    Technol Cancer Res Treat; 2014 Apr; 13(2):95-100. PubMed ID: 23919391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.
    Guckenberger M; Wilbert J; Richter A; Baier K; Flentje M
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):901-8. PubMed ID: 20708850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy.
    Wang B; Wang DQ; Lin MS; Lu SP; Zhang J; Chen L; Li QW; Cheng ZK; Liu FJ; Guo JY; Liu H; Qiu B
    BMC Cancer; 2020 Nov; 20(1):1112. PubMed ID: 33198676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of cone beam CT in the adaptive radiotherapy planning process for non-small-cell lung cancer patients.
    Duffton A; Harrow S; Lamb C; McJury M
    Br J Radiol; 2016 Jun; 89(1062):20150492. PubMed ID: 27052681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adaptive MR-CT registration method for MRI-guided prostate cancer radiotherapy.
    Zhong H; Wen N; Gordon JJ; Elshaikh MA; Movsas B; Chetty IJ
    Phys Med Biol; 2015 Apr; 60(7):2837-51. PubMed ID: 25775937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 4-dimensional computed tomography to 4-dimensional cone-beam computed tomography deformable image registration for lung cancer adaptive radiation therapy.
    Balik S; Weiss E; Jan N; Roman N; Sleeman WC; Fatyga M; Christensen GE; Zhang C; Murphy MJ; Lu J; Keall P; Williamson JF; Hugo GD
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):372-9. PubMed ID: 23462422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative accuracy of 4D dose accumulation for lung radiotherapy using rigid dose projection versus dose recalculation on every breathing phase.
    Valdes G; Lee C; Tenn S; Lee P; Robinson C; Iwamoto K; Low D; Lamb JM
    Med Phys; 2017 Mar; 44(3):1120-1127. PubMed ID: 28019649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung sparing and dose escalation in a robust-inspired IMRT planning method for lung radiotherapy that accounts for intrafraction motion.
    McCann C; Purdie T; Hope A; Bezjak A; Bissonnette JP
    Med Phys; 2013 Jun; 40(6):061705. PubMed ID: 23718584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
    Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
    Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
    Xiao L; Liu N; Zhang G; Zhang H; Gao S; Fu Z; Wang S; Yu Q; Yu J; Yuan S
    PLoS One; 2017; 12(1):e0170901. PubMed ID: 28125698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.
    Guckenberger M; Kavanagh A; Partridge M
    Strahlenther Onkol; 2012 Oct; 188(10):894-900. PubMed ID: 22933031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
    Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients.
    St-Hilaire J; Sévigny C; Beaulieu F; Germain F; Lavoie C; Dagnault A; Gingras L; Tremblay D; Beaulieu L
    Radiother Oncol; 2009 Jun; 91(3):342-8. PubMed ID: 19135749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression models for predicting physical and EQD
    Wang H; Zhou Y; Gan W; Chen H; Huang Y; Duan Y; Feng A; Shao Y; Gu H; Kong Q; Xu Z
    Radiat Oncol; 2021 Jun; 16(1):119. PubMed ID: 34176503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planning study.
    Marnitz S; Stuschke M; Bohsung J; Moys A; Reng I; Wurm R; Budach V
    Strahlenther Onkol; 2002 Nov; 178(11):651-8. PubMed ID: 12426677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of dynamic adaptive passive scattering proton therapy with computed tomography image guidance in the lung.
    Moriya S; Tachibana H; Hotta K; Nakamura N; Sakae T; Akimoto T
    Med Phys; 2017 Sep; 44(9):4474-4481. PubMed ID: 28665491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.